Cryoglobulin activity and N-linked oligosaccharide content of 6-19, 6-19Q6E/K23A, and 6-19N471T mAbs
mAb . | Ig isotype . | Vh6/23* . | Cryoglobulin† . | Oligosaccharide‡ . |
---|---|---|---|---|
6-19 | IgG3 | Q/K | 29 | 112 |
6-19Q6E/K23A | IgG3 | E/A | 14 | 112 |
6-19N471T | IgG3 | Q/K | 27 | 108 |
SS2F8 | IgG1 | Q/K | < 1 | 115 |
mAb . | Ig isotype . | Vh6/23* . | Cryoglobulin† . | Oligosaccharide‡ . |
---|---|---|---|---|
6-19 | IgG3 | Q/K | 29 | 112 |
6-19Q6E/K23A | IgG3 | E/A | 14 | 112 |
6-19N471T | IgG3 | Q/K | 27 | 108 |
SS2F8 | IgG1 | Q/K | < 1 | 115 |
mAb indicates monoclonal antibody; Ig, immunoglobulin; Q, glutamine; E, glutamic acid; K, lysine; A, alanine.
Amino acid residues at positions 6 and 23 of heavy chains.
Concentrations of IgG (μg/mL) in cryoprecipitates recovered following the incubation of mAb (1 mg/mL) for 48 hours at 4°C.
Amounts of N-linked oligosaccharides liberated from different 6-19 mAbs (unit/mg of IgG3). One unit of oligosaccharides was designated as 1 μL of ABEE-oligosaccharide solution with the absorbance at 304 nm equals 1.0.